Jon J. Snyder - Founder, President, and CEO.  Over 20 years of domestic and international management experience in biomedical and healthcare sales, marketing,  operations, and venture capital investment at start-up and Fortune 500 (Top 20) companies including Cyberonics, Cardinal Health, Imalux, and STERIS Corporation. 

Zi-Ping Fang, PhD - Chief Technology Officer.  PhD in Biomedical Engineering focused on neurostimulation technology from Case Western Reserve University. Over 25 years of neurostimulation R&D in product design and animal and clinical research leading to FDA approval, including technology leadership and management and executive responsibility in neurostimulation startup business development and operations including Nevro and NeuroControl.

Mark W. Teague - Chief Operating Officer.  Founder and principal of The Colonnade Corporation, a private equity investment firm focused on acquiring small, well-established, Midwest manufacturing companies.  Colonnade and its successors acquired several businesses which Mr. Teague served as shareholder, board member, and in a variety of interim operating management roles, successfully selling these businesses to strategic and financial buyers.  Previously, originated and executed public and private corporate finance transactions for McDonald & Company.

 
Management Team